Home / Pharmaceutical / The Pharmaceutical Market: Sudan & South Sudan

The Pharmaceutical Market: Sudan & South Sudan

Published: Dec 2014 | No Of Pages: 60 | Published By: ERC

Product Synopsis

Sudan & South Sudan Pharmaceuticals & Healthcare Report
 
Sudan and South Sudan's will continue to be of least interest to foreign pharmaceutical firms in the Middle East and North Africa region as the countries are plagued by high inflation, fiscal constraints and underdeveloped non-oil economies. Political risk remains elevated as many disputes between them are still unresolved. These macroeconomic uncertainties will mean lack of focus on public healthcare provision, which further complicates the problem that the general population are unable to afford expensive pharmaceuticals. 
 
Headline ExpenditureProjections
  • Pharmaceuticals: SDG1.49bn (US$556mn) in 2011 to SDG1.93bn (US$472mn) in 2012; 30.0% in local currency terms with a contraction of 15.1% in US dollar terms. Forecast unchanged from Q4 12.
  • Healthcare: SDG11.01bn (US$4.12mn) in 2011 to SDG13.44bn (US$3.29bn) in 2012; +22.0% in local currency terms and -20% in US dollar terms. Forecastdown slightly from Q4 12's,due to reassessment of historic values.
Competitive Landscape
 
The competitive landscape section provides comparative company analyses and rankings by US$ sales and % share of total sales - for the total pharmaceutical sector, as well as the OTC, generics, and distribution sub-sectors.
BMI Industry View7
SWOT9
Political10
Economic11
Business Environment12
Industry Forecast13
Pharmaceutical Market Forecast13
 
Table: Pharmaceutical Sales, Historical Data And Forecasts (Sudan 2010-2018)18
 
Healthcare Market Forecast19
 
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Sudan 2010-2018)21
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Sudan 2010-2018)21
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Sudan 2010-2018)22
 
Macroeconomic Forecasts23
Economic Analysis - Sudan23
 
Table: Economic Activity (Sudan 2009-2018)28
 
Industry Risk Reward Ratings29
Middle East & Africa Risk/Reward Ratings29
Sudan Risk/Reward Ratings36
Rewards36
Risks36
Market Overview38
Industry Trends And Developments40
Regulatory Development43
Regulatory Regime43
Demographic Forecast45
Demographic Forecast - Sudan45
 
Table: Sudan's Population By Age Group, 1990-2020 ('000)46
Table: Sudan's Population By Age Group, 1990-2020 (% of total)47
Table: Sudan's Key Population Ratios, 1990-202048
Table: Sudan's Rural And Urban Population, 1990-202048
 
Demographic Forecast - South Sudan49
 
Table: South Sudan's Population By Age Group, 1990-2020 ('000)50
Table: South Sudan's Population By Age Group, 1990-2020 (% of total)51
Table: South Sudan's Key Population Ratios, 1990-202052
Table: South Sudan's Urban And Rural Population, 1990-202052
 
Glossary53
Methodology55
Pharmaceutical Expenditure Forecast Model55
Healthcare Expenditure Forecast Model55
Notes On Methodology56
Risk/Reward Ratings Methodology57
Ratings Overview58
 
Table: Pharmaceutical Risk/Reward Ratings Indicators58
 
Indicator Weightings59
Choose License Type
 
Contact Information
24/7 Research Support
Phone: +1-855-455-8662
sales@acutemarketreports.com
Get in Touch with us
join us on Facebook
Follow us on Twitter
Follow us on LinkedIn
Add us on Google +